- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Mendus AB (IMMUN)
Mendus AB stock price live, this page displays ST IMMUN stock exchange data. View the IMMUN premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Mendus AB real time stock price chart below.
What Is the Mendus AB Stock Price Today?
The Mendus AB stock price today is 5.140.
What Is the Stock Symbol for Mendus AB?
The stock symbol for Mendus AB is "IMMUN."
What Stock Exchange Does Mendus AB Trade On?
Mendus AB is listed and trades on the Stockholm stock exchange.
Is Mendus AB a Good Stock to Buy?
Determining whether Mendus AB—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the IMMUN quote. (ISIN: SE0022239950)
What Is the Mendus AB Stock Price Today?
The Mendus AB stock price today is 5.140.
What Is the Stock Symbol for Mendus AB?
The stock symbol for Mendus AB is "IMMUN."
What Stock Exchange Does Mendus AB Trade On?
Mendus AB is listed and trades on the Stockholm stock exchange.
Is Mendus AB a Good Stock to Buy?
Determining whether Mendus AB—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the IMMUN quote. (ISIN: SE0022239950)
Stockholm
Currency in SEK
5.140
+0.295(+6.09%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
4.800
5.490
52 wk Range
4.455
11.200
IMMUN Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
IMMUN is not included in our AI-picked strategies. See which stocks are.
Review Strategies
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
4.8005.490
52 wk Range
4.45511.200
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
IMMUN Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Price Target
27.000
Upside
+425.29%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
No news in this category
Looks like there are no results in this news category
Mendus AB Company Profile
Mendus AB (publ), a biopharmaceutical company, develops immunotherapies for the treatment of tumor recurrence and established tumors. Its lead product is vididencel (DCP-001), which is in Phase II ADVANCE-II clinical trial for the treatment of acute myeloid leukemia (AML); Phase II CADENCE clinical trial to treat AML; and Phase I ALISON clinical trial for the treatment of ovarian cancers. The company also develops ilixadencel, which is in phase 1/2 clinical trial for the treatment of soft tissue sarcomas; and an NK cell program, which is in a preclinical study for NK cell-based therapies. It has an alliance with NorthX Biologic to support large-scale manufacturing and commercial launch of vididencel; and the Australasian Leukaemia and Lymphoma Group to expand the clinical development of vididencel as a maintenance treatment for AML. The company was formerly known as Immunicum AB (publ) and changed its name to Mendus AB (publ) in June 2022. Mendus AB (publ) was incorporated in 2002 and is headquartered in Stockholm, Sweden.
Compare IMMUN to Peers and Sector
Metrics to compare | IMMUN | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipIMMUNPeersSector | |
|---|---|---|---|---|
P/E Ratio | −2.1x | −10.9x | −0.4x | |
PEG Ratio | −0.07 | −0.23 | 0.00 | |
Price/Book | 0.4x | 7.1x | 2.6x | |
Price / LTM Sales | −179.3x | 47.9x | 2.9x | |
Upside (Analyst Target) | - | 71.4% | 51.7% | |
Fair Value Upside | Unlock | 0.4% | 9.5% | Unlock |
Analyst Ratings
1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 27.000
(+425.29% Upside)
Earnings
Latest Release
May 06, 2025
EPS / Forecast
-0.61 / -0.7288
Revenue / Forecast
1.34M / --
People Also Watch
FAQ
What Is the Mendus AB (IMMUN) Stock Price Today?
The Mendus AB stock price today is 5.14
What Stock Exchange Does Mendus AB Trade On?
Mendus AB is listed and trades on the Stockholm Stock Exchange stock exchange.
What Is the Stock Symbol for Mendus AB?
The stock symbol for Mendus AB is "IMMUN."
What Is the Mendus AB Market Cap?
As of today, Mendus AB market cap is 258.85M.
What Is Mendus AB's Earnings Per Share (TTM)?
The Mendus AB EPS (TTM) is -2.45.
When Is the Next Mendus AB Earnings Date?
Mendus AB will release its next earnings report on 20 Aug 2025.
From a Technical Analysis Perspective, Is IMMUN a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Mendus AB Stock Split?
Mendus AB has split 4 times.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.